Tests For Infliximab Antibodies And Infliximab Drug Level Testing

Информация о тендерe

Open procedure
27.06.2013 13:43 (GMT+02:00)
23.08.2013 12:00 (GMT+02:00)

Информация о покупателе

Helse Bergen HF Helse Bergen HF
Julie Rinde Julie Rinde, Innkjøpsseksjonen
Postboks 1,
5021 Bergen
Норвегия

Closing date has passed.

Информация о тендере

The Contracting Authority invites tenders for the following partial deliveries/product groups:

1.Enzyme Linked Immunosorbent Assay (ELISA) based or equivalent (non-radioactive) kit designed for determination of antibodies to infliximab in serum / plasma.

2.Enzyme Linked Immunosorbent Assay (ELISA) based or equivalent (non-radioactive) kit designed for monitoring drug levels of infliximab in serum/ plasma of patients during treatment.

Also see Part 2 – Appendix 2 – Specification for further details.

Merk: For å melde din interesse i denne kunngjøringen og motta tilleggsinformasjon vennligst besøk Doffin nettsiden http://www.doffin.no/Search/Search_Switch.aspx?ID=299033.

Закупочная документация

Название Объем
Part_1_-_Rules_for_competetive_tendering.docx 113 KB
Part_1_Appendix_A_-_Tender_Letter.docx 42 KB
Part_1_Appendix_B_-_Information_about_the_tenderer.docx 41 KB
Part_1_Appendix_C__-_HSE_declaration.docx 40 KB
Part_2_-_Draft_Contract.docx 116 KB
Part_2_Appendix_1_-_Pricing_schedule.xls 48 KB
Part_2_Appendix_2_-_Specification.xlsx 111 KB
Part_2_Appendix_3_-_Delivery_locations.xlsx 15 KB

Mercell Holding AS

Part of the Mercell Group, one of Europe’s leading providers of e tender systems and information between buyers and suppliers in the professional market.

Contact us

Write to us

+47 21 01 88 00